| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARIAD PHARMACEUTICALS INC | 12,850,000 | 105,884,000 | 22.33% | ||
| 2 | ABBVIE INC | 1,580,000 | 92,493,000 | 19.51% | ||
| 3 | QUEST DIAGNOSTICS INC | 775,000 | 59,559,000 | 12.56% | ||
| 4 | AMGEN INC | 318,000 | 50,832,000 | 10.72% | ||
| 5 | AEGERION PHARMACEUTICALS INC | 1,637,455 | 42,852,000 | 9.04% | ||
| 6 | MEDICINES CO | 1,215,100 | 34,047,000 | 7.18% | ||
| 7 | MERCK & CO INC | 400,000 | 22,992,000 | 4.85% | ||
| 8 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 875,000 | 15,733,000 | 3.32% | ||
| 9 | Apricus Biosciences, Inc. | 6,524,505 | 12,201,000 | 2.57% | ||
| 10 | REPROS THERAPEUTICS INC | 1,132,367 | 9,727,000 | 2.05% | ||
| 11 | INTRA CELLULAR THERAPIES INC COM | 360,000 | 8,597,000 | 1.81% | ||
| 12 | VIVUS INC | 2,573,943 | 6,332,000 | 1.34% | ||
| 13 | KINDRED BIOSCIENCES INC | 689,091 | 4,920,000 | 1.04% | ||
| 14 | AVEO PHARMACEUTICALS INC | 2,570,759 | 3,728,000 | 0.79% | ||
| 15 | ANI PHARMACEUTICALS INC COM | 31,000 | 1,939,000 | 0.41% | ||
| 16 | TARGACEPT INC | 630,000 | 1,871,000 | 0.39% | ||
| 17 | ELEVEN BIOTHERAPEUTICS INC | 41,200 | 368,000 | 0.08% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-15-019796, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
